Screener
Recursion Pharmaceuticals, Inc. RXRX Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $1.95B.
The source filing: Recursion Pharmaceuticals, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 6:32 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001601830-26-000098
FAQ
- What is Recursion Pharmaceuticals, Inc.'s market capitalization?
- Recursion Pharmaceuticals, Inc. (RXRX) reported market capitalization of $1.95B in Q2 2026.
- How has Recursion Pharmaceuticals, Inc.'s market capitalization changed year-over-year?
- Recursion Pharmaceuticals, Inc.'s market capitalization decreased by 8.2% year-over-year, from $2.12B to $1.95B.
- What is the long-term trend for Recursion Pharmaceuticals, Inc.'s market capitalization?
- Over 4 years (2021 to 2025), Recursion Pharmaceuticals, Inc.'s market capitalization has grown at a -7.6% compound annual growth rate (CAGR), from $2.92B to $2.13B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about Recursion Pharmaceuticals, Inc.'s market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude